Clomiphene Citrate in Obesity - Associated Hypogonadism

Mateus Andrade Misson, Carlos Oliveira Leal Neto, Lucas Querino Wirz, Daniel Martins Borges, Thalita Leal Leite Pimenta

Abstract: This study investigates the benefits of Clomiphene Citrate CC in treating obesity-associated secondary hypogonadism. An integrative review was conducted, focusing on pharmacodynamic principles, risk-benefit, safety, and therapeutic effectiveness. The study concludes that CC is a safe and effective therapy for hypogonadotropic hypogonadism, especially beneficial for those desiring fatherhood.

Keywords: Hypogonadism. Male Obesity, ClomiphenCitrat. Fertility, Hypothalamic-Pituitary-Gonadal Axis

How to Cite?: Mateus Andrade Misson, Carlos Oliveira Leal Neto, Lucas Querino Wirz, Daniel Martins Borges, Thalita Leal Leite Pimenta, "Clomiphene Citrate in Obesity - Associated Hypogonadism", Volume 12 Issue 8, August 2023, International Journal of Science and Research (IJSR), Pages: 61-66, https://www.ijsr.net/getabstract.php?paperid=SR23729182057, DOI: https://dx.doi.org/10.21275/SR23729182057